BR100 Decreased By (-0.73%)
BR30 Decreased By (-1.09%)
KSE100 Decreased By (-0.38%)
KSE30 Decreased By (-0.43%)
AGHA 7.57 Decreased By ▼ -0.08 (-1.05%)
BECO 5.18 Decreased By ▼ -0.03 (-0.58%)
BML 58.52 Increased By ▲ 0.23 (0.39%)
BOP 33.90 Decreased By ▼ -0.71 (-2.05%)
CNERGY 10.94 Increased By ▲ 0.18 (1.67%)
CSIL 5.52 Decreased By ▼ -0.17 (-2.99%)
FCCL 55.85 Decreased By ▼ -0.62 (-1.1%)
FFL 16.21 Decreased By ▼ -0.64 (-3.8%)
FNEL 1.21 Decreased By ▼ -0.02 (-1.63%)
KEL 7.40 Decreased By ▼ -0.07 (-0.94%)
KOSM 6.05 Decreased By ▼ -0.13 (-2.1%)
LOTCHEM 27.60 Decreased By ▼ -0.08 (-0.29%)
MLCF 96.90 Increased By ▲ 0.34 (0.35%)
NBP 206.67 Decreased By ▼ -1.93 (-0.93%)
NCPL 56.76 Decreased By ▼ -1.37 (-2.36%)
NPL 66.88 Decreased By ▼ -0.73 (-1.08%)
OGDC 321.01 Decreased By ▼ -2.44 (-0.75%)
PACE 10.50 Decreased By ▼ -0.21 (-1.96%)
PAEL 43.00 Decreased By ▼ -0.37 (-0.85%)
PIBTL 16.68 Decreased By ▼ -0.12 (-0.71%)
PPL 223.00 Decreased By ▼ -1.67 (-0.74%)
PRL 58.75 Increased By ▲ 3.24 (5.84%)
PTC 70.25 Decreased By ▼ -0.82 (-1.15%)
SSGC 25.90 Decreased By ▼ -0.07 (-0.27%)
TBL 9.78 No Change ▼ 0.00 (0%)
TELE 8.60 Decreased By ▼ -0.05 (-0.58%)
TPL 19.85 Increased By ▲ 0.24 (1.22%)
TPLP 12.81 Decreased By ▼ -0.37 (-2.81%)
TREET 22.75 Increased By ▲ 0.08 (0.35%)
TRG 60.49 Increased By ▲ 0.44 (0.73%)
By

WASHINGTON: Former US president Joe Biden is undergoing radiation and hormone therapy to fight prostate cancer that was revealed in May, a spokesperson said Saturday.

“As part of a treatment plan for prostate cancer, President Biden is currently undergoing radiation therapy and hormone treatment,” the spokesperson said. In May, the 82 year old ex-president’s office announced that Biden had been diagnosed with an aggressive form of prostate cancer that spread to his bones after he experienced urinary symptoms and a prostate nodule was found. “Cancer touches us all.

Like so many of you, Jill and I have learned that we are strongest in the broken places,” Biden, whose son Beau Biden died of cancer in 2015, said at the time in a post on X.

Comments

Comments are closed for this article.